Citation: Ke Gong, Jinghan Liao, Jiangtao Lin, Quan Wang, Zhihua Wu, Liting Wang, Jiali Zhang, Yi Dong, Yourong Duan, Jianhua Chen. Mitochondria-targeted nanoparticles overcome chemoresistance via downregulating BACH1/CD47 axis in ovarian carcinoma[J]. Chinese Chemical Letters, ;2024, 35(5): 108888. doi: 10.1016/j.cclet.2023.108888 shu

Mitochondria-targeted nanoparticles overcome chemoresistance via downregulating BACH1/CD47 axis in ovarian carcinoma

Ke Gong ^{a, 1} ,
Jinghan Liao ^{a, 1} ,
Jiangtao Lin ^a ,
Quan Wang ^a ,
Zhihua Wu ^a ,
Liting Wang ^a ,
Jiali Zhang ^a ,
Yi Dong ^{b, *,} ,
Yourong Duan ^{a, *,} ,
Jianhua Chen ^{c, *,}

a.
State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China
b.
Department of Ultrasound, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China
c.
Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

dong.yi@shsmu.edu.cn

yrduan@shsci.org

jianhuachen15@163.com

Received Date: 6 June 2023
Revised Date: 1 August 2023
Accepted Date: 3 August 2023
Available Online: 4 August 2023

Figures(4)

The platinum-based chemotherapy is a routine strategy for the treatment of ovarian cancer, while it is prone to chemoresistance in clinical, which hinders the treatment. Therefore, it is urgently needed to elucidate the underlying mechanism of drug resistance and form the appropriate strategy. The sequencing results showed that cisplatin (DDP) resistant ovarian cancer overexpressed BTB and CNC homology 1 (BACH1), and up-regulated the “don't eat me” signal CD47. We identified that hemin, a BACH1 inhibitor, could effectively down-regulate BACH1 and simultaneously inhibit CD47. Moreover, hemin has a synergistic effect with DDP. We designed a pH-responsive nanoparticle (H/D@FA–CaP–NPs) in which folic acid (FA) ensured targeting of ovarian cancer cells, while hemin inhibited BACH1 as well as down-regulated CD47, achieving the promotion of apoptosis of tumor cells and inducing phagocytosis of tumors by macrophages. Moreover, hemin has a synergistic effect with DDP to promote apoptosis of tumor cells. Structurally, hemin and DDP was encapsulated within hydrophobic 1,2-distearoyl-sn-glycero-3-phospho-ethanolamine (DSPE) to form a tight core, and hydrophilic polyethylene glycol 2000 (PEG2000) and calcium phosphate (CaP) formed the outside shell, and FA was modified on the surface of nanoparticles. In terms of function, (a) FA enhanced the active targeting of nanoparticles to tumors; (b) NPs targeted mitochondria to induce reactive oxygen species (ROS) production; (c) hemin encapsulated in nanoparticles could specifically target BACH1, thereby down regulating CD47; (d) hemin had a synergistic effect with DDP, thus augmenting the chemotherapy. Altogether, mitochondria-targeted nanoparticles H/D@FA–CaP–NPs promoted tumor apoptosis and mobilized phagocytosis to treat tumor, providing a novel scheme for clinical treatment of cisplatin-resistant ovarian carcinoma.
- Cisplatin-resistant,
- Hemin,
- BACH1,
- CD47,
- Phagocytosis,
- ROS,
- Synergistic effect
1. [1]
  B.M. Reid, J.B. Permuth, T.A. Sellers, Cancer Biol. Med. 14 (2017) 9–32. doi: 10.20892/j.issn.2095-3941.2016.0084
2. [2]
  R.L. Siegel, K.D. Miller, H.E. Fuchs, et al., CA Cancer J. Clin. 72 (2022) 7–33. doi: 10.3322/caac.21708
3. [3]
  L. Tian, B. Xu, K.Y. Teng, et al., Clin. Cancer Res. 28 (2022) 201–214. doi: 10.1158/1078-0432.ccr-21-1248
4. [4]
  T. Pejovic, K. Fitch, G. Mills, Cancer Drug Resist. 5 (2022) 451–458. doi: 10.20517/cdr.2021.138
5. [5]
  A. Simeonov, A. Yasgar, A. Jadhav, et al., Anal. Biochem. 375 (2008) 60–70. doi: 10.1016/j.ab.2007.11.039
6. [6]
  M.T. Reilly, K.A. Cunningham, A. Natarajan, Neuropsychopharmacology 34 (2009) 247–248. doi: 10.1038/npp.2008.167
7. [7]
  S. Davudian, B. Mansoori, N. Shajari, et al., Gene 588 (2016) 30–37. doi: 10.1016/j.gene.2016.04.040
8. [8]
  Y. Liang, H. Wu, R. Lei, et al., J. Biol. Chem. 287 (2012) 33533–33544. doi: 10.1074/jbc.M112.392332
9. [9]
  J. Yun, C.A. Frankenberger, W.L. Kuo, et al., EMBO J. 30 (2011) 4500–4514. doi: 10.1038/emboj.2011.312
10. [10]
  W. Han, Y. Zhang, C. Niu, et al., Cancer Lett. 445 (2019) 45–56. doi: 10.1016/j.canlet.2019.01.003
11. [11]
  J. Lee, A.E. Yesilkanal, J.P. Wynne, et al., Nature 568 (2019) 254–258. doi: 10.1038/s41586-019-1005-x
12. [12]
  C. Liu, Y. Wang, Front. Public Health 10 (2022) 902445. doi: 10.3389/fpubh.2022.902445
13. [13]
  Y. Kojima, J.P. Volkmer, K. McKenna, Nature 536 (2016) 86–90. doi: 10.1038/nature18935
14. [14]
  S. Kaur, K.V. Cicalese, R. Bannerjee, et al., Antib. Ther. 3 (2020) 179–192. doi: 10.1093/abt/tbaa017
15. [15]
  S.B. Willingham, J.P. Volkmer, A.J. Gentles, et al., Proc. Natl. Acad. Sci. U. S. A. 109 (2012) 6662–6667. doi: 10.1073/pnas.1121623109
16. [16]
  M. Logtenberg, F.A. Scheeren, T.N. Schumacher, Immunity 52 (2020) 742–752. doi: 10.1016/j.immuni.2020.04.011
17. [17]
  K. Ogawa, J. Sun, S. Taketani, et al., EMBO J. 20 (2001) 2835–2843. doi: 10.1093/emboj/20.11.2835
18. [18]
  M.M. Zhang, R. Bahal, T.P. Rasmussen, et al., Biochem. Pharmacol. 189 (2021) 114432. doi: 10.1016/j.bcp.2021.114432
19. [19]
  R. Pisa, T.M. Kapoor, Nat. Chem. Biol. 16 (2020) 817–825. doi: 10.1038/s41589-020-0596-8
20. [20]
  W. Chen, Y. Xiao, X. Liu, et al., Chem. Commun. 49 (2013) 4932–4934. doi: 10.1039/c3cc41872c
21. [21]
  W. Chen, X. Liu, Y. Xiao, et al., Small 10 (2014) 3644–3649. doi: 10.1002/smll.201303849
22. [22]
  J.T. Huckaby, S.K. Lai, Adv. Drug Deliv. Rev. 124 (2018) 125–139. doi: 10.1016/j.addr.2017.08.010
23. [23]
  J. Hu, X. Yuan, F. Wang, et al., Chin. Chem. Lett. 32 (2021) 1341–1347. doi: 10.1016/j.cclet.2020.11.006
24. [24]
  W. Chen, X. Liu, Y. Xiao, et al., Small 11 (2015) 1775–1781. doi: 10.1002/smll.201402377
25. [25]
  J. Sun, J. Li, X. Li, et al., Chin. Chem. Lett. 34 (2023) 107891. doi: 10.1016/j.cclet.2022.107891
26. [26]
  A. Youssef, M.B. Haskali, K.L. Gorringe, Cancers 13 (2021) 5596. doi: 10.3390/cancers13225596
27. [27]
  P. Giampaolino, V. Foreste, L. Della Corte, et al., Gland Surg. 9 (2020) 1102–1111. doi: 10.21037/gs-20-544
28. [28]
  K. Liu, Z. Jiang, F. Zhao, et al., Adv. Mater. 34 (2022) e2206594. doi: 10.1002/adma.202206594
29. [29]
  Y. Wu, Y. Zhang, L. Dai, et al., J. Control. Release 316 (2019) 236–249. doi: 10.1016/j.jconrel.2019.10.043
30. [30]
  M.Z. Zhang, A. Ishii, N. Nishiyama, et al., Adv. Mater. 21 (2009) 3520–3525. doi: 10.1002/adma.200800448
31. [31]
  B.D. White, C. Duan, H.E. Townley, Biomolecules 9 (2019) 202. doi: 10.3390/biom9050202
32. [32]
  H. Maeda, J. Wu, T. Sawa, et al., J. Control. Release 65 (2000) 271–284. doi: 10.1016/S0168-3659(99)00248-5
33. [33]
  G.C. Jayson, E.C. Kohn, H.C. Kitchener, et al., Lancet 384 (2014) 1376–1388. doi: 10.1016/S0140-6736(13)62146-7
34. [34]
  W.P. McGuire, J. Clin. Oncol. 27 (2009) 4633–4634. doi: 10.1200/JCO.2009.23.6653
35. [35]
  S. Vaughan, J.I. Coward, R.C. Bast Jr, et al., Nat. Rev. Cancer 11 (2011) 719–725. doi: 10.1038/nrc3144
36. [36]
  L.P. Martin, T.C. Hamilton, R.J. Schilder, Clin. Cancer Res. 14 (2008) 1291–1295. doi: 10.1158/1078-0432.CCR-07-2238
37. [37]
  C.A. Rabik, M.E. Dolan, Cancer Treat. Rev. 33 (2007) 9–23. doi: 10.1016/j.ctrv.2006.09.006
38. [38]
  T.C. Chou, Cancer Res. 70 (2010) 440–446.
39. [39]
  C.L. Wang, M.J. Lin, C.Y. Hsu, et al., Biomed. Pharmacother. 119 (2019) 109105. doi: 10.1016/j.biopha.2019.109105
40. [40]
  H. Wang, M. Tan, S. Zhang, et al., Int. J. Mol. Sci. 16 (2015) 3391–3404. doi: 10.3390/ijms16023391
41. [41]
  N. Li, C.X. Zhang, X.X. Wang, et al., Biomaterials 34 (2013) 3366–3380. doi: 10.1016/j.biomaterials.2013.01.055
42. [42]
  J. Song, C. Lin, X. Yang, et al., J. Control. Release 294 (2019) 27–42. doi: 10.1016/j.jconrel.2018.11.014
43. [43]
  C. Wang, S. Chen, Y. Wang, et al., Adv. Mater. 30 (2018) e1706407. doi: 10.1002/adma.201706407
44. [44]
  L. Huang, Z. Sun, Q. Shen, et al., Chin. Chem. Lett. 33 (2022) 4146–4156. doi: 10.1016/j.cclet.2022.02.047
45. [45]
  J. Sun, L. Jiang, Y. Lin, et al., Int. J. Nanomed. 12 (2017) 1517–1537. doi: 10.2147/IJN.S122859
46. [46]
  C. Yue, Y. Yang, J. Song, et al., Nanoscale 9 (2017) 11103–11118. doi: 10.1039/C7NR02193C
47. [47]
  H. Ni, M. Guo, X. Zhang, et al., Cancer Biol. Med. 18 (2021) 139–154. doi: 10.20892/j.issn.2095-3941.2020.0151
48. [48]
  J.D. Hayes, A.T. Dinkova-Kostova, K.D. Tew, Cancer Cell 38 (2020) 167–197. doi: 10.1016/j.ccell.2020.06.001
1. [1]
  Zimo Peng , Quan Zhang , Gaocan Qi , Hao Zhang , Qian Liu , Guangzhi Hu , Jun Luo , Xijun Liu . Nanostructured Pt@RuOx catalyst for boosting overall acidic seawater splitting. Chinese Journal of Structural Chemistry, 2024, 43(1): 100191-100191. doi: 10.1016/j.cjsc.2023.100191
2. [2]
  Fengrui Yang , Debing Wang , Xinying Zhang , Jie Zhang , Zhichao Wu , Qiaoying Wang . Synergistic effects of peroxydisulfate on UV/O₃ process for tetracycline degradation: Mechanism and pathways. Chinese Chemical Letters, 2024, 35(10): 109599-. doi: 10.1016/j.cclet.2024.109599
3. [3]
  Maosen Xu , Pengfei Zhu , Qinghong Cai , Meichun Bu , Chenghua Zhang , Hong Wu , Youzhou He , Min Fu , Siqi Li , Xingyan Liu . In-situ fabrication of TiO₂/NH₂−MIL-125(Ti) via MOF-driven strategy to promote efficient interfacial effects for enhancing photocatalytic NO removal activity. Chinese Chemical Letters, 2024, 35(10): 109524-. doi: 10.1016/j.cclet.2024.109524
4. [4]
  Liping Zhao , Xixi Guo , Zhimeng Zhang , Xi Lu , Qingxuan Zeng , Tianyun Fan , Xintong Zhang , Fenbei Chen , Mengyi Xu , Min Yuan , Zhenjun Li , Jiandong Jiang , Jing Pang , Xuefu You , Yanxiang Wang , Danqing Song . Novel berberine derivatives as adjuvants in the battle against Acinetobacter baumannii: A promising strategy for combating multi-drug resistance. Chinese Chemical Letters, 2024, 35(10): 109506-. doi: 10.1016/j.cclet.2024.109506
5. [5]
  Xuejie Gao , Xinyang Chen , Ming Jiang , Hanyan Wu , Wenfeng Ren , Xiaofei Yang , Runcang Sun . Long-lifespan thin Li anode achieved by dead Li rejuvenation and Li dendrite suppression for all-solid-state lithium batteries. Chinese Chemical Letters, 2024, 35(10): 109448-. doi: 10.1016/j.cclet.2023.109448
6. [6]
  Kexin Dong , Chuqi Shen , Ruyu Yan , Yanping Liu , Chunqiang Zhuang , Shijie Li . Integration of Plasmonic Effect and S-Scheme Heterojunction into Ag/Ag₃PO₄/C₃N₅ Photocatalyst for Boosted Photocatalytic Levofloxacin Degradation. Acta Physico-Chimica Sinica, 2024, 40(10): 2310013-. doi: 10.3866/PKU.WHXB202310013
7. [7]
  Yixuan Wang , Jiexin Li , Zhihao Shang , Chengcheng Feng , Jianmin Gu , Maosheng Ye , Ran Zhao , Danna Liu , Jingxin Meng , Shutao Wang . Wettability-driven synergistic resistance of scale and oil on robust superamphiphobic coating. Chinese Chemical Letters, 2024, 35(7): 109623-. doi: 10.1016/j.cclet.2024.109623
8. [8]
  Xiangqian Cao , Chenkai Yang , Xiaodong Zhu , Mengxin Zhao , Yilin Yan , Zhengnan Huang , Jinming Cai , Jingming Zhuang , Shengzhou Li , Wei Li , Bing Shen . Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM. Chinese Chemical Letters, 2024, 35(8): 109199-. doi: 10.1016/j.cclet.2023.109199
9. [9]
  Xin Li , Xuan Ding , Junkun Zhou , Hui Shi , Zhenxi Dai , Jiayi Liu , Yongcun Ma , Penghui Shao , Liming Yang , Xubiao Luo . Utilizing synergistic effects of bifunctional polymer hydrogel PAM-PAMPS for selective capture of Pb(Ⅱ) from wastewater. Chinese Chemical Letters, 2024, 35(7): 109158-. doi: 10.1016/j.cclet.2023.109158
10. [10]
  Huijiao Fu , Peiqin Liang , Qianwen Chen , Yan Wang , Guang Li , Xuzi Cai , Shengtao Wang , Kun Chen , Shengying Shi , Zhiqiang Yu , Xuefeng Wang . COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: An allicin-based nanomedicine approach. Chinese Chemical Letters, 2024, 35(8): 109241-. doi: 10.1016/j.cclet.2023.109241
11. [11]
  Zengchao Guo , Weiwei Liu , Tengfei Liu , Jinpeng Wang , Hui Jiang , Xiaohui Liu , Yossi Weizmann , Xuemei Wang . Engineered exosome hybrid copper nanoscale antibiotics facilitate simultaneous self-assembly imaging and elimination of intracellular multidrug-resistant superbugs. Chinese Chemical Letters, 2024, 35(7): 109060-. doi: 10.1016/j.cclet.2023.109060
12. [12]
  Fanxin Kong , Hongzhi Wang , Huimei Duan . Inhibition effect of sulfation on Pt/TiO2 catalysts in methane combustion. Chinese Journal of Structural Chemistry, 2024, 43(5): 100287-100287. doi: 10.1016/j.cjsc.2024.100287
13. [13]
  Min Fu , Pan He , Sen Zhou , Wenqiang Liu , Bo Ma , Shiying Shang , Yaohao Li , Ruihan Wang , Zhongping Tan . An unexpected stereochemical effect of thio-substituted Asp in native chemical ligation. Chinese Chemical Letters, 2024, 35(8): 109434-. doi: 10.1016/j.cclet.2023.109434
14. [14]
  Yixia Zhang , Caili Xue , Yunpeng Zhang , Qi Zhang , Kai Zhang , Yulin Liu , Zhaohui Shan , Wu Qiu , Gang Chen , Na Li , Hulin Zhang , Jiang Zhao , Da-Peng Yang . Cocktail effect of ionic patch driven by triboelectric nanogenerator for diabetic wound healing. Chinese Chemical Letters, 2024, 35(8): 109196-. doi: 10.1016/j.cclet.2023.109196
15. [15]
  Yuan Dong , Mutian Ma , Zhenyang Jiao , Sheng Han , Likun Xiong , Zhao Deng , Yang Peng . Effect of electrolyte cation-mediated mechanism on electrocatalytic carbon dioxide reduction. Chinese Chemical Letters, 2024, 35(7): 109049-. doi: 10.1016/j.cclet.2023.109049
16. [16]
  Botao Gao , He Qi , Hui Liu , Jun Chen . Role of polarization evolution in the hysteresis effect of Pb-based antiferroelecrtics. Chinese Chemical Letters, 2024, 35(4): 108598-. doi: 10.1016/j.cclet.2023.108598
17. [17]
  Xin Huang , Yi Zhao , Wanzhen Liang . Vibronic coupling effect on intersystem crossing rates of TADF emitters. Chinese Journal of Structural Chemistry, 2024, 43(6): 100278-100278. doi: 10.1016/j.cjsc.2024.100278
18. [18]
  Cunjun Li , Wencong Liu , Xianlei Chen , Liang Li , Shenyu Lan , Mingshan Zhu . Adsorption and activation of peroxymonosulfate on BiOCl for carbamazepine degradation: The role of piezoelectric effect. Chinese Chemical Letters, 2024, 35(10): 109652-. doi: 10.1016/j.cclet.2024.109652
19. [19]
  Xuejian Xing , Pan Zhu , E Pang , Shaojing Zhao , Yu Tang , Zheyu Hu , Quchang Ouyang , Minhuan Lan . D-A-D-structured boron-dipyrromethene with aggregation-induced enhanced phototherapeutic efficiency for near-infrared fluorescent and photoacoustic imaging-guided synergistic photodynamic and photothermal cancer therapy. Chinese Chemical Letters, 2024, 35(10): 109452-. doi: 10.1016/j.cclet.2023.109452
20. [20]
  Linjie Ju , Zhongxi Huang , Qian Shen , Chan Fu , Shuanghe Li , Wenjie Duan , Chenfeng Xu , Weizhen An , Zhiqiang Zhai , Jifu Wei , Changmin Yu , Guoren Zhou . Glutathione depletion based Pt(Ⅳ) hybrid mesoporous organosilica delivery system to conquer cisplatin chemoresistance: A “one stone three birds” strategy. Chinese Chemical Letters, 2024, 35(10): 109450-. doi: 10.1016/j.cclet.2023.109450

Get Citation

PDF

XML

Metrics

PDF Downloads(1)
Abstract views(118)
HTML views(0)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142